377 related articles for article (PubMed ID: 19202708)
1. [Cerebral sinovenous thrombosis and acquired antithrombin, protein C and S deficiency during chemotherapy in a young man: report of a case].
Munoz VT; Triffet A; Cauchie P; Brohée D
Rev Med Brux; 2008; 29(6):535-9. PubMed ID: 19202708
[TBL] [Abstract][Full Text] [Related]
2. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
[TBL] [Abstract][Full Text] [Related]
3. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
[TBL] [Abstract][Full Text] [Related]
4. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro study.
Kuhle S; Lau A; Bajzar L; Vegh P; Halton J; Cherrick I; Anderson R; Desai S; McCusker P; Wu J; Abshire T; Mahoney D; Mitchell L
Br J Haematol; 2006 Sep; 134(5):526-31. PubMed ID: 16856890
[TBL] [Abstract][Full Text] [Related]
6. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study.
Mitchell L; Andrew M; Hanna K; Abshire T; Halton J; Wu J; Anderson R; Cherrick I; Desai S; Mahoney D; McCusker P; Chait P; Abdolell M; de Veber G; Mikulis D
Thromb Haemost; 2003 Aug; 90(2):235-44. PubMed ID: 12888870
[TBL] [Abstract][Full Text] [Related]
7. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Beinart G; Damon L
Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin supplementation III in childhood acute lymphoblastic leukemia treated with L-asparaginase.
Matsuzaki A; Suminoe A; Hara T
Pediatr Hematol Oncol; 2002 Dec; 19(8):601-3. PubMed ID: 12487838
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
[TBL] [Abstract][Full Text] [Related]
10. [Thrombophilias associated with cerebral venous thrombosis].
Schlück E; Rodier G; Derouiche F; Bronner P; Boulay C; Courtois S; Cohen E
Rev Neurol (Paris); 2002 May; 158(5 Pt 1):543-52. PubMed ID: 12072822
[TBL] [Abstract][Full Text] [Related]
11. [Inherited thrombophilia and arterial diseases].
Robert-Ebadi H; Boehlen F; de Moerloose P
Rev Med Suisse; 2007 Feb; 3(97):331-2, 334-5. PubMed ID: 17370730
[TBL] [Abstract][Full Text] [Related]
12. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
Lim HL; Teo CP; Wong K; Kueh YK
Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
[TBL] [Abstract][Full Text] [Related]
13. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
[TBL] [Abstract][Full Text] [Related]
14. [Superior sagittal sinus thrombosis following L-asparaginase therapy of acute lymphoblastic leukemia].
Watanabe I; Sakai I; Matsumoto I
Rinsho Ketsueki; 1992 Mar; 33(3):343-8. PubMed ID: 1578639
[TBL] [Abstract][Full Text] [Related]
15. Deficiencies of natural anticoagulants, protein C, protein S, and antithrombin.
Lipe B; Ornstein DL
Circulation; 2011 Oct; 124(14):e365-8. PubMed ID: 21969320
[No Abstract] [Full Text] [Related]
16. Thrombophilia and complex acquired deficiencies of antithrombin, protein C, and protein S.
Humphries JE
Semin Hematol; 1995 Oct; 32(4 Suppl 2):8-16; discussion 17-8. PubMed ID: 8821205
[No Abstract] [Full Text] [Related]
17. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
[TBL] [Abstract][Full Text] [Related]
18. [Cerebral thrombosis in a child with acute lymphocytic leukemia during L-asparaginase therapy].
Horigome Y; Hanada T; Inudoh M; Takita H
Rinsho Ketsueki; 1989 Aug; 30(8):1284-8. PubMed ID: 2601047
[TBL] [Abstract][Full Text] [Related]
19. Cerebral sinovenous thrombosis during asparaginase treatment. Case 3.
Leibundgut K; Hirt A; Zwicky C; Wuillemin WA
Hamostaseologie; 2003 Aug; 23(3):109-12. PubMed ID: 12923578
[TBL] [Abstract][Full Text] [Related]
20. An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events.
Farrell K; Fyfe A; Allan J; Tait RC; Leach M
Leuk Lymphoma; 2016 Nov; 57(11):2568-74. PubMed ID: 27078747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
